David H. Adams

2.7k total citations
36 papers, 1.3k citations indexed

About

David H. Adams is a scholar working on Rheumatology, Immunology and Psychiatry and Mental health. According to data from OpenAlex, David H. Adams has authored 36 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Rheumatology, 11 papers in Immunology and 10 papers in Psychiatry and Mental health. Recurrent topics in David H. Adams's work include Psoriasis: Treatment and Pathogenesis (11 papers), Spondyloarthritis Studies and Treatments (10 papers) and Rheumatoid Arthritis Research and Therapies (10 papers). David H. Adams is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (11 papers), Spondyloarthritis Studies and Treatments (10 papers) and Rheumatoid Arthritis Research and Therapies (10 papers). David H. Adams collaborates with scholars based in United States, Canada and United Kingdom. David H. Adams's co-authors include Bruce J. Kinon, Joanna Chikwe, Shinobu Itagaki, Hong Liu‐Seifert, Matthew Seigerman, John P. Houston, Paul Cavallaro, Brian A. Millen, Anelechi Anyanwu and Nana Toyoda and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and Hepatology.

In The Last Decade

David H. Adams

36 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David H. Adams United States 20 487 289 287 258 200 36 1.3k
Margaret R. Warner United States 23 349 0.7× 247 0.9× 307 1.1× 54 0.2× 102 0.5× 60 1.8k
Clark Paramore United States 11 339 0.7× 87 0.3× 195 0.7× 134 0.5× 104 0.5× 26 1.1k
Ramesh K. Gupta India 20 26 0.1× 215 0.7× 185 0.6× 253 1.0× 119 0.6× 74 1.4k
Anthony Pereira United Kingdom 16 198 0.4× 63 0.2× 75 0.3× 357 1.4× 402 2.0× 46 990
Chiara Falcone Italy 18 129 0.3× 157 0.5× 179 0.6× 284 1.1× 158 0.8× 30 1.1k
Tim Schneider Germany 23 55 0.1× 145 0.5× 68 0.2× 210 0.8× 330 1.6× 72 1.4k
Brian G. Kral United States 19 367 0.8× 264 0.9× 54 0.2× 121 0.5× 161 0.8× 51 990
Kazuo Suzuki Japan 17 215 0.4× 51 0.2× 46 0.2× 202 0.8× 363 1.8× 38 973
Yannick Kaiser Netherlands 18 495 1.0× 402 1.4× 26 0.1× 142 0.6× 164 0.8× 34 1.2k
Teruhide Koyama Japan 17 87 0.2× 92 0.3× 74 0.3× 72 0.3× 99 0.5× 57 831

Countries citing papers authored by David H. Adams

Since Specialization
Citations

This map shows the geographic impact of David H. Adams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David H. Adams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David H. Adams more than expected).

Fields of papers citing papers by David H. Adams

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David H. Adams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David H. Adams. The network helps show where David H. Adams may publish in the future.

Co-authorship network of co-authors of David H. Adams

This figure shows the co-authorship network connecting the top 25 collaborators of David H. Adams. A scholar is included among the top collaborators of David H. Adams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David H. Adams. David H. Adams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heijde, Désirée van der, Mikkel Østergaard, John D. Reveille, et al.. (2021). Spinal Radiographic Progression and Predictors of Progression in Patients With Radiographic Axial Spondyloarthritis Receiving Ixekizumab Over 2 Years. The Journal of Rheumatology. 49(3). 265–273. 25 indexed citations
2.
Coates, Laura C., Sreekumar Pillai, Hasan Tahir, et al.. (2021). Withdrawing Ixekizumab in Patients With Psoriatic Arthritis Who Achieved Minimal Disease Activity: Results From a Randomized, Double‐Blind Withdrawal Study. Arthritis & Rheumatology. 73(9). 1663–1672. 16 indexed citations
3.
Landewé, Robert, Lianne S. Gensler, Denis Poddubnyy, et al.. (2021). Continuing versus withdrawing ixekizumab treatment in patients with axial spondyloarthritis who achieved remission: efficacy and safety results from a placebo-controlled, randomised withdrawal study (COAST-Y). Annals of the Rheumatic Diseases. 80(8). 1022–1030. 19 indexed citations
4.
Genovese, Mark C., Eduardo Mysler, Tetsuya Tomita, et al.. (2020). Safety of ixekizumab in adult patients with plaque psoriasis, psoriatic arthritis and axial spondyloarthritis: data from 21 clinical trials. Lara D. Veeken. 59(12). 3834–3844. 52 indexed citations
5.
Kavanaugh, Arthur, Helena Marzo‐Ortega, Ronald Vender, et al.. (2019). Ixekizumab improves patient-reported outcomes in patients with active psoriatic arthritis and inadequate response to tumour necrosis factor inhibitors: SPIRIT-P2 results to 52 weeks.. PubMed. 37(4). 566–574. 23 indexed citations
6.
Coates, Laura C., Ana‐Maria Orbai, Akimichi Morita, et al.. (2018). Achieving minimal disease activity in psoriatic arthritis predicts meaningful improvements in patients’ health-related quality of life and productivity. BMC Rheumatology. 2(1). 24–24. 25 indexed citations
7.
Merola, Joseph F., Phoebe Rich, Jan Dutz, et al.. (2018). THU0313 Ixekizumab improves nail and skin lesions through 52 weeks in patients with active psoriatic arthritis and inadequate response to tumour necrosis factor inhibitors. Annals of the Rheumatic Diseases. 77. 374–375. 1 indexed citations
8.
Nisenbaum, Laura, Fangyi Zhao, Brian A. Millen, et al.. (2016). Serotonin 2A Receptor SNP rs7330461 Association with Treatment Response to Pomaglumetad Methionil in Patients with Schizophrenia. Journal of Personalized Medicine. 6(1). 9–9. 14 indexed citations
9.
Quraishi, Mohammed Nabil, Martin J. Sergeant, Gemma L. Kay, et al.. (2014). Parallel 19: Cholestatic Liver Diseases. Hepatology. 60. 264A–267A. 5 indexed citations
10.
Chikwe, Joanna, et al.. (2013). National Outcomes in Acute Aortic Dissection: Influence of Surgeon and Institutional Volume on Operative Mortality. The Annals of Thoracic Surgery. 95(5). 1563–1569. 186 indexed citations
11.
Houston, John P., Bonnie A. Fijal, Alexandra N. Heinloth, & David H. Adams. (2009). Genetic associations of prolactin increase in olanzapine/fluoxetine combination-treated patients. Psychiatry Research. 175(1-2). 171–172. 14 indexed citations
12.
Adams, David H., Anelechi Anyanwu, Joanna Chikwe, & Farzan Filsoufi. (2009). The Year in Cardiovascular Surgery. Journal of the American College of Cardiology. 53(25). 2389–2403. 3 indexed citations
13.
Perlis, Roy H., Bonnie A. Fijal, David H. Adams, et al.. (2008). Variation in Catechol-O-Methyltransferase Is Associated with Duloxetine Response in a Clinical Trial for Major Depressive Disorder. Biological Psychiatry. 65(9). 785–791. 64 indexed citations
14.
Lipkovich, Ilya, David H. Adams, Craig Mallinckrodt, et al.. (2008). Evaluating dose response from flexible dose clinical trials. BMC Psychiatry. 8(1). 3–3. 31 indexed citations
15.
16.
Brown, Eileen, David L. Dünner, Susan L. McElroy, et al.. (2008). Olanzapine/fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression. The International Journal of Neuropsychopharmacology. 12(6). 773–773. 51 indexed citations
17.
Rahmanian, Parwis B., Javier G. Castillo, Javier Sanz, David H. Adams, & Farzan Filsoufi. (2007). Cardiac myxoma: preoperative diagnosis using a multimodal imaging approach and surgical outcome in a large contemporary series. Interactive Cardiovascular and Thoracic Surgery. 6(4). 479–483. 44 indexed citations
18.
Liu‐Seifert, Hong, David H. Adams, & Bruce J. Kinon. (2005). Discontinuation of treatment of schizophrenic patients is driven by poor symptom response: a pooled post-hoc analysis of four atypical antipsychotic drugs. BMC Medicine. 3(1). 21–21. 120 indexed citations
19.
Adams, David H.. (2000). Dirac operator index and topology of lattice gauge fields. Chinese Journal of Physics. 38(3). 633–646. 2 indexed citations
20.
Cohn, Lawrence H., Sary F. Aranki, Robert J. Rizzo, et al.. (1993). Decrease in operative risk of reoperative valve surgery. The Annals of Thoracic Surgery. 56(1). 15–21. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Margaret R. Warner Breakdown of academic impact, for papers by Clark Paramore Breakdown of academic impact, for papers by Ramesh K. Gupta Breakdown of academic impact, for papers by Anthony Pereira Breakdown of academic impact, for papers by Chiara Falcone Breakdown of academic impact, for papers by Tim Schneider Breakdown of academic impact, for papers by Brian G. Kral Breakdown of academic impact, for papers by Kazuo Suzuki Breakdown of academic impact, for papers by Yannick Kaiser Breakdown of academic impact, for papers by Teruhide Koyama
Rankless by CCL
2026